The FDA has approved the first combination, targeted regimen for previously untreated BRAF V600E mutation-positive metastatic ...

In today’s Pharmaceutical Executive Daily, the FDA approves Braftovi for mutant metastatic colorectal cancer, Novo Nordisk ...

Advances in organ and computer models are raising the prospect that some animal experiments could be eliminated. But there are still huge hurdles to overcome.

Astellas Pharma Inc. and Vir Biotechnology Inc. have signed a global co-development pact to advance VIR-5500, Vir’s PRO-XTEN dual-masked CD3 T-cell engager targeting prostate-specific membrane antigen ...

The first engineered cell therapy has come to the fight against solid tumors. Fox Chase Cancer Center has begun using Tecelra, an FDA-approved treatment for synovial sarcoma.

IRSF investment positions organization at the forefront of early-stage Rett research as genomic medicine reshapes rare ...

24/7 Market News encourages readers and industry observers to obtain a copy of this month’s National Geographic to review the full feature and explore the scientific context in depth. Interested ...

As California’s AB 2034 moves forward, the bill targeting self-affirmed GRAS ingredients is intensifying debate over state authority, federal reform and the risk of patchwork food safety regulation.

Popular weight-loss drugs, including Ozempic, Wegovy, Trulicity and Mounjaro, produced by independent pharmacy labs, sickened ...

Larimar Therapeutics (LRMR) stock surges on FDA Breakthrough Therapy status for its lead asset, nomlabofusp, in Friedreich’s ...

What to eat? GRAS status allows manufacturers to use approved ingredients in food without undergoing repeated evaluations.